[115] described that phosphoglycerate dehydrogenase (PHGDH), involved in the synthesis of serine and glycine from glucose, is critical for pancreatic tumor cells proliferation and tumorigenesis, mediating cell-tight junctions formation, mTOR activation (through Akt), and protein expression and translation, after interaction with the translation initiation factors eIF4A1 and eIF4E (which seems to be independent of its enzymatic activity)
Excessive mtROS production or impaired antioxidant defenses disrupts redox homeostasis and mitochondrial dynamics [87], leading to mtDNA damage and impaired mitophagy, thereby amplifying mitochondrial dysfunction [88, 89]
Each bottle contains 30 tablets , making it convenient for a full months daily use
GHK-Cu + BPC-157 + TB-500 (GLOW Stack) GHK-Cu: 1.5 to 2 mg per day BPC-157: 250 to 500 mcg per day TB-500: 250 to 500 mcg per day Duration: 4 weeks on, 2 to 4 weeks rest The GLOW stack (sometimes sold as a pre-mixed blend at a 5:1:1 ratio) covers all three phases of tissue repair: acute healing (BPC-157), systemic signals (TB-500), and collagen remodeling (GHK-Cu)
found that TMAO can inhibit the RCT process and affect cholesterol metabolism ( ApoE / mice, and further activate the nuclear receptors farnesoid-X-receptor (FXR) and small heterodimer partner (SHP), to reduce the expression of cholesterol 7-hydroxylase (Cyp7a1) to inhibit bile acid synthesis, thus accelerating the formation of atherosclerosis (82)
Weeks beyond the last dose, in tissue repair contexts
